alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 62, Number 232 (Wednesday, December 3, 1997)]
[Notices]
[Page 63928]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-31647]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission
[Docket No. GT98-6-000]


Northwest Pipeline Corporation; Notice of Proposed Changes in 
FERC Gas Tariff and Filing of Non-Conforming Service Agreement

November 26, 1997.
    Take notice that on November 21, 1997, Northwest Pipeline 
Corporation (Northwest) tendered for filing and acceptance (1) a non-
conforming service agreement with Kimball Energy Corporation (Kimball) 
effective November 1, 1997, and (2) First Revised Sheet No. 364 of its 
FERC Gas Tariff, Third Revised Volume No. 1, to be effective November 
1, 1997.
    Northwest states that the service agreement is non-conforming 
because it includes provisions that establish priorities of service for 
Kimball that are subordinate to other firm shippers. The tariff sheet 
is submitted to add such agreement to the list of non-conforming 
service agreements contained in Northwest's tariff, and to remove from 
the list the service agreement with U.S. Gas Transportation, Inc., 
which has expired.
    Any person desiring to be heard or protest this filing should file 
a motion to intervene or protest with the Federal Energy Regulatory 
Commission, 888 First Street, NE., Washington, DC 20426, in accordance 
with Sections 385.214 and 385.211 of the Commission's Rules and 
Regulations. All such motions or protests must be filed as provided in 
Section 154.210 of the Commission's Regulations. Protests will be 
considered by the Commission in determining the appropriate action to 
be taken, but will not serve to make protestants parties to the 
proceeding. Any person wishing to become a party must file a motion to 
intervene. Copies of this filing are on file with the Commission and 
are available for public inspection in the Public Reference Room.
Linwood A. Watson, Jr.,
Acting Secretary.
[FR Doc. 97-31647 Filed 12-2-97; 8:45 am]
BILLING CODE 6717-01-M
Exhibit 31.1

CERTIFICATIONS

I, L.
Daniel Browne, certify that:

1. I have reviewed this annual report on Form 10-K of Revance Therapeutics, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The
registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusion about
the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(c) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the
registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over
financial reporting.

5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants
internal control over financial reporting.

Date: March 28, 2014



/s/ L. Daniel BrowneL. Daniel BrownePresident and Chief Executive Officer(Principal Executive Officer)
* Pursuant to 5th CIR. R. 47.5, the court has determined that this

opinion should not be published and is not precedent except under the

limited circumstances set forth in 5th CIR. R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 97-40786

Summary Calendar

DOUGLAS EDWARD ALLEN,

Plaintiff-Appellant,

versus

B.C. CHANEY, Assistant Warden, Joe F. Gurney Unit, ET AL.,

Defendant-Appellee.

Appeal from the United States District Court

for the Eastern District of Texas

USDC No. 6:96-CV-758

February 3, 1999

Before JOHNSON, HIGGINBOTHAM, and DAVIS, Circuit Judges.

PER CURIAM:*

Douglas Edward Allen, Texas prisoner # 728150, filed a civil rights

complaint pursuant to 42 U.S.C. § 1983 against Brenda Chaney, in her

capacity as the Assistant Warden at the Joe F. Gurney Unit; Michael

Ford, in his capacity as Correctional Officer; William Matthew, in his

capacity as Sergeant; and Nolan Pittock, in his capacity as Captain.

He argued that the defendants were deliberately indifferent to his

serious medical needs when he was assigned to a prison job that did not

conform to his medical classification. Allen also contended that he was

subjected to false disciplinary proceedings. In his complaint, Allen
2

requested that the matter be tried by a jury.

The magistrate judge issued an order scheduling an evidentiary

hearing pursuant to Flowers v. Phelps, 956 F.2d 488 (5th Cir.), modified

on other grounds, 964 F.2d 400 (5th Cir. 1992). Based on the evidence

presented at the hearing, the magistrate judge recommended that Allen’s

case be dismissed. The district court adopted the magistrate judge’s

recommendation and dismissed the complaint with prejudice.

Allen did not waive his jury demand by participating in the Flowers

hearing without objection. See McAfee v. Martin, 63 F.3d 436, 437-38

(5th Cir. 1995). In McAfee, the court stated that “because the right

to a jury trial is a fundamental right . . . courts should indulge every

reasonable presumption against waiver. A waiver should not be found in

a doubtful situation. “ Id. at 437 (internal quotations and citations

omitted). Accordingly, the judgement of the district court is VACATED,

and the case is REMANDED to the district court for additional

proceedings.

VACATE and REMAND.
[Federal Register Volume 62, Number 230 (Monday, December 1, 1997)]
[Notices]
[Pages 63552-63553]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-31417]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Allergy and Infectious Diseases Special Emphasis 
Panel (SEP) meeting:

    Name of SEP: Therapeutic Strategies for Papillomavirus 
(Telephone Conference Call).
    Date: December 17, 1997.
    Time: 2:00 p.m. to Adjournment.
    Place: Teleconference, 6003 Executive Blvd., Solar Building, 
Room 1A1, Bethesda, MD 20892, (301) 402-0747.
    Contact Person: Rosemary McCabe Hamill, Technical Evaluation 
Admin., 6003 Executive Boulevard, Solar Bldg., Room 3C03, Bethesda, 
MD 20892, (301) 496-0384.
    Purpose/Agenda: To evaluate contract proposal.
    The meeting will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure

[[Page 63553]]

of which would constitute a clearly unwarranted invasion of personal 
privacy.
    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review and funding cycle.

(Catalog of Federal Domestic Assistance Programs Nos. 93.855, 
Immunology, Allergic and Immunologic Diseases Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health.)

    Dated: November 24, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-31417 Filed 11-28-97; 8:45 am]
BILLING CODE 4140-01-M
#### Mrs. Bertie Mae AULTMAN et al. v. Mrs. Mamie GRAVES et al.

No. 45598.

Supreme Court of Mississippi.

Feb. 9, 1970.

John K. Keyes, Collins, for appellants.

Donald G. Kruger, Prentiss, for appel-lees.

Affirmed.

PER CURIAM.
Exhibit 31.3

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

I, Thomas H. Pike, certify that:



| | 1. | I have reviewed this annual report on Form 10-K/A (Amendment No. 1) of Quintiles Transnational Holdings Inc. and
| | -- | ----------------------------------------------------------------------------------------------------------------



| | 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this report.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                        |  |  |  |                              
|----------------------- |  |  |  | -----------------------------
|Date: February 21, 2014 |  |  |  | /s/ Thomas H. Pike           
|                        |  |  |  | Thomas H. Pike               
|                        |  |  |  | Chief Executive Officer      
|                        |  |  |  | (Principal Executive Officer)
EXHIBIT 32.2








CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002








In connection with the Annual Report of Active Health Foods, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gregory Manos, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief:





1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.








March 14, 2011
By:
/s/ GREGORY MANOSGregory ManosPresident, CEO, Director and

Principal Financial Officer
Exhibit 13.1



Certification
Pursuant to 18 U.S.C. Section 1350



Pursuant to U.S.C. Section 1350 of the
Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned
officers of Prime Acquisition Corp. (the “Company”), does hereby certify, to such officer’s knowledge, that:



The Annual Report on Form 20-F for the
year ended December 31, 2012 of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange
Act of 1934 and information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results
of operations of the Company.



|Date: December 2, 2014 |     |                                             
|---------------------- | --- | --------------------------------------------
|                       | By: | /s/ William Tsu-Cheng Yu                    
|                       |     | William Tsu-Cheng Yu                        
|                       |     | Interim Chief Executive Officer and Chairman
|                       |     | (Principal Executive Officer)               



|Date: December 2, 2014 |     |                                             
|---------------------- | --- | --------------------------------------------
|                       | By: | /s/ Amy Lau                                 
|                       |     | Amy Lau                                     
|                       |     | Interim Chief Financial Officer             
|                       |     | (Principal Financial and Accounting Officer)
ECIP Applicants Affected by Hurricane Ida

The deadline to submit an application for investment through the Emergency Capital Investment 

Program (ECIP) is Wednesday, September 1, 2021 at 11:59 PM ET.

Prospective ECIP applicants may request a seven-day extension of the application deadline if they are 

unable to submit a timely application due directly to the impacts of Hurricane Ida. To request an 

application deadline extension, an applicant must: 

• Submit a request to Treasury in writing (such as by e-mail) that explains why it cannot submit its 

application by the September 1, 2021, deadline, such as whether (1) the applicant’s offices were 

closed or without electricity for a significant period; (2) staff members were not able to work on the 

application during critical periods; or (3) application partners (e.g., consultants, community partners) 

were not able to provide materials critical to the compilation of the application; and

• State that the applicant’s headquarters or principal place of business are in, or the applicant has 

been materially affected by disaster-related conditions in, a parish or county that the Federal 

Emergency Management Agency (FEMA) has designated as affected by a “major disaster” declared 

since August 29, 2021.1

If the circumstances that led to the extension request continue after seven days, prospective applicants

may request an extension of an additional seven days by submitting a request, consistent with the 

requirements above, regarding the continued impact of the disaster on the applicant. All initial requests 

for extensions must be submitted by Wednesday, September 8, 2021 at 5:00 p.m. Eastern Time.

If you would like to request an application deadline extension, you must send your request via e-mail to 

ecip@treasury.gov with the subject line “Deadline Extension Request.” If you are unable to file your 

request by e-mail, you may contact the ECIP Program by telephone at (202) 819-3127. 

1 As of 5 PM Eastern Time on August 31, 2021, this includes only Ascension, Assumption, East Baton Rouge, East 

Feliciana, Iberia, Iberville, Jefferson, Lafourche, Livingston, Orleans, Plaquemines, Pointe Coupee, St. Bernard, St. 

Charles, St. Helena, St. James, St. John the Baptist, St. Martin, St. Mary, St. Tammany, Tangipahoa, Terrebonne, 

Washington, West Baton Rouge and West Feliciana parishes in Louisiana.
I 

117TH CONGRESS 

1ST SESSION H. R. 1913 

To authorize the extension of nondiscriminatory treatment (normal trade 

relations treatment) to products of Uzbekistan. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 16, 2021 

Mr. KELLY of Mississippi (for himself and Mr. BACON) introduced the 

following bill; which was referred to the Committee on Ways and Means 

A BILL 

To authorize the extension of nondiscriminatory treatment 

(normal trade relations treatment) to products of Uzbekistan. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Uzbekistan Normalized 

5 Trade Act’’. 

6 SEC. 2. TERMINATION OF APPLICATION OF TITLE IV OF 

7 THE TRADE ACT OF 1974 TO PRODUCTS OF 

8 UZBEKISTAN. 

9 (a) PRESIDENTIAL DETERMINATIONS AND EXTEN10 SION OF NONDISCRIMINATORY TREATMENT.—NotwithVerDate Sep 11 2014 21:51 May 11, 2021 Jkt 019200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H1913.IH H1913

pamtmann on DSKBC07HB2PROD with BILLS
2 

•HR 1913 IH

1 standing any provision of title IV of the Trade Act of 1974 

2 (19 U.S.C. 2431 et seq.), the President may— 

3 (1) determine that such title should no longer 

4 apply to Uzbekistan; and 

5 (2) after making a determination under para6 graph (1) with respect to Uzbekistan, proclaim the 

7 extension of nondiscriminatory treatment (normal 

8 trade relations treatment) to the products of Uzbek9 istan. 

10 (b) TERMINATION OF APPLICABILITY OF TITLE

11 IV.—On and after the date on which the President ex12 tends nondiscriminatory treatment to the products of Uz13 bekistan pursuant to subsection (a), title IV of the Trade 

14 Act of 1974 (19 U.S.C. 2431 et seq.) shall cease to apply 

15 to Uzbekistan. 

Æ 


pamtmann on DSKBC07HB2PROD with BILLS
Docket number: FAA-2014-0752
[Federal Register Volume 62, Number 232 (Wednesday, December 3, 1997)]
[Notices]
[Pages 63955-63956]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-31637]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting of the National Cancer Institute Special Emphasis Panel (SEP):
    Name of SEP: Informatics Support for Breast and Colon Cancer 
Cooperative Family Registries.
    Date: December 8, 1997.
    Time: 9:00 a.m. to Adjournment.
    Place: Executive Plaza North, Conference Room C, 6130 Executive 
Boulevard, Bethesda, MD 20892.
    Contact Person: Courtney M. Kerwin, Ph.D., M.P.H., Scientific 
Review Administrator, National Cancer Institute, NIH, Executive 
Plaza North, Room 630I, 6130

[[Page 63956]]

Executive Boulevard, MSC 7405, Bethesda, MD 20892-7405, Telephone: 
301/496-7421.
    Purpose/Agenda: To review, discuss and evaluate grant 
applications.

    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review and funding cycle.
    The meeting will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications 
and the discussions could reveal confidential trade secrets or 
commercial property such as patentable material and personal 
information concerning individuals associated with the applications, 
the disclosure of which would constitute a clearly unwarranted invasion 
of personal privacy.

(Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396; 
Cancer Biology Research; 93.397, Cancer Centers Support; 93:398, 
Cancer Research Manpower; 93.399, Cancer Control)

    Dated: November 25, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-31637 Filed 12-2-97; 8:45 am]
BILLING CODE 4140-01-M
```

[Federal Register Volume 75, Number 220 (Tuesday, November 16, 2010)]
[Notices]
[Page 69916]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-28809]

-----------------------------------------------------------------------

DEPARTMENT OF AGRICULTURE

Agricultural Research Service

Notice of Intent To Grant Exclusive License

AGENCY: Agricultural Research Service, USDA.

ACTION: Notice of intent.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. Department of 
Agriculture, Agricultural Research Service, intends to grant to 
American Packaging Corporation of Rochester, New York, an exclusive 
license to U.S. Patent No. 7,387,205, ``Packaging System for Preserving 
Perishable Items'', issued on June 17, 2008.

DATES: Comments must be received on or before December 16, 2010.

ADDRESSES: Send comments to: USDA, ARS, Office of Technology Transfer, 
5601 Sunnyside Avenue, Rm. 4-1174, Beltsville, Maryland 20705-5131.

FOR FURTHER INFORMATION CONTACT: June Blalock of the Office of 
Technology Transfer at the Beltsville address given above; telephone: 
301-504-5989.

SUPPLEMENTARY INFORMATION: The Federal Government's patent rights in 
this invention are assigned to the United States of America, as 
represented by the Secretary of Agriculture. It is in the public 
interest to so license this invention as American Packaging Corporation 
of Rochester, New York has submitted a complete and sufficient 
application for a license. The prospective exclusive license will be 
royalty-bearing and will comply with the terms and conditions of 35 
U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be 
granted unless, within thirty (30) days from the date of this published 
Notice, the Agricultural Research Service receives written evidence and 
argument which establishes that the grant of the license would not be 
consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.

Richard J. Brenner,
Assistant Administrator.
[FR Doc. 2010-28809 Filed 11-15-10; 8:45 am]
BILLING CODE 3410-03-P
```
#### Jack L. BYRD, Appellant, v. Neill M. MICHAEL and Bert G. Gross, Appellees.

No. 73-305.

District Court of Appeal of Florida, Fourth District.

Dec. 14, 1973.

Rehearing Denied Jan. 16, 1974.

Joseph A. Rosier, Orlando, for appellant.

John D. Mendez, Fort Lauderdale, for appellees.

DOWNEY, Judge.

In the court below appellees sued appellant for a real estate brokerage commission and prevailed. The sole point there and here was whether the transaction was “closed” so as to entitle the appellees to their commission. The trial court held it was closed and entered judgment for the commission.

On the record before us at this time, absent any suggestion of fraud on appellant’s part, we find the sale was not closed as provided in the brokerage contract and that appellees’’ suit was premature. Accordingly, the judgment appealed from is reversed with directions to dismiss the cause,

WALDEN and MAGER, JJ., concur.